September 14, 2018
This morning maker of heart failure management and remote monitoring devices Endotronix scored $45 million in a Series D financing round led by LSP, with participation from Aperture Venture Partners, BioVentures Investors, Lumira Ventures, OSF Ventures, Seroba Life Sciences, SV Health Investors, Wanxiang Healthcare Investments, and an unnamed corporate investor.
“We are thrilled with the world-...
March 12, 2018
A new study, sponsored by the US Department of Veterans Affairs, applied wearable biosensors to post-acute heart failure patients and deployed FDA-cleared analytics from vendor physIQ to detect vital sign anomalies.
It demonstrated promising predictive power for artificial intelligence-based analytics in terms of sensitivity, specificity and early warning lead time – suggesting the potential to...
December 21, 2017
Intermountain Healthcare researchers have created a new app to monitor heart failure patients and identify when their condition becomes advanced.
The app monitors medical tests and health status and quickly alerts clinicians that the heart patient’s care needs have changed. When computer monitoring indicates a patient likely has advanced heart failure, the app automatically sends a secure email...
June 29, 2017
The Duke Clinical Research Institute, funded by a grant from Novartis, is launching a large-scale study to explore the effectiveness of mobile apps in the treatment of heart failure patients. The study, called Connect HF, is aiming to enroll 8,000 patients across 160 hospitals by the end of fall 2018, with results hoped for by the end of 2020.
"CONNECT HF is a clinical trial looking at different...
May 3, 2017
San Francisco-based ReThink Medical raised $3 million to develop a medical wearable to predict and prevent heart failure. The round was led by Emergent Medical with additional funding from Norwich Ventures and Launch Capital. The company is also operating with a previously-awarded NIH grant as well as a strategic partnership with Japanese medical device company Terumo Corporation, which includes...
May 1, 2017
Boston Children's Hospital is the latest to tackle the problem of continuity of care between a patient's doctor and any emergency room or urgent care center they might find themselves in. And they're testing the technology, from startup Position Health, in some of their smallest and most high risk patients.
"At Boston Children’s we have a population of very high risk infants with severe...
August 11, 2016
Medical technology company ImpediMed launched a direct-to-consumer connected device that tracks body composition, fluid status and hydration in a variety of settings.
SOZO is two-pound, sensor-enabled scale with a connected stand and platform cradle to rest either a tablet or smartphone. The users steps on the scale, which has eight body sensors and four weight sensors, waits a few seconds and...
July 14, 2016
Chicago-based Endotronix, which makes devices to manage heart failure and remotely monitor cardiac patients, has raised $32 million in new funding. Investors included BioVentures, SV Life Sciences, Lumira Capital, Aperture Venture Partners and OSF Ventures. Existing investors as well as an unnamed corporate investor also participated. This brings Endotronix's total funding to date to $50 million...
May 5, 2015
Mountain View, California-based Amiigo, which makes an activity tracker that raised $580,000 on Indiegogo in 2013, has teamed up with online patient community platform Alliance Health to launch a new study looking at the combined effect of wearables and peer support on heart failure patients.
“There are a lot of different questions we can begin to ask related to the value of a social networking...
April 23, 2015
A retrospective matched-pair cohort study of 348 patients in Partners HealthCare's Boston-area hospitals shows that remote monitoring in congestive heart failure patients can reduce 120-day hospitalizations and mortality. Interestingly, while the reduction in mortality held beyond the 120 days of the study, the hospitalizations for the monitoring cohort actually went up after the monitoring...